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1. Introduction 
The use of plants as medicines is dated back to early man (Phillipson, 2001). Humans relied 
on nature for their basic needs such as food, shelter, clothing, fertilizers, flavours, fragrances 
and last but not least medicines. Plants have formed the sophisticated traditional medicine 
systems that have been in existence for thousands of years (Anon, 1998, Yelisida, 2005; 
Cunningham, 1993).  
Traditional medicine refers to the health practices, approaches, knowledge and beliefs 
incorporating plants, animals and mineral based medicines, spiritual therapies, manual 
techniques and exercises, applied singularly or in-combination to treat, diagnose and 
prevent illnesses or maintain well-being of individuals. Medicine, in several developing 
countries, using local traditions and beliefs, is still the mainstay health care till to date. The 
practice of traditional medicine is widespread in China, India, Japan, Pakistan, Sri Lanka 
and South Africa etc (Hoareau and Dasilva, 1999; Coetzee et al, 1999; Diederichs, 2002, Nair, 
2005). In China 40% of the total medicinal consumption is attributed to traditional tribal 
medicines. In Japan, herbal medicine preparations are more in demand than mainstream 
pharmaceutical products (Hoareau and Dasilva, 1999).  
Africa is a rich source of medicinal plants (Hoareau and Dasilva, 1999). They are an integral 
part of African culture, which is the oldest and most diverse in the world. Plants have been 
used in African medicine to treat fever, asthma, constipation, hypertension, skin diseases etc 
(Medical news press). About 80% of the black population uses traditional medicine as the 
primary healthcare system (Bussman and Sharon, 2006, Van wyk et al 1997).  
1.1 Uses of plants 
Plants are a source of fuel, building material, craft material, dyes, food supplements and 
medicine all over the world. Approximately 80% of black population make use/ rely on 
plants for these services (Light, 2005). Traditional medicine can be viewed as a parallel 
system to western health care. Approximately 3000 species are used by an estimated 200,000 
indigenous traditional healers (Van wyk et al. 1997). Plants can be used for different 
purposes, some of them are mentioned below: 
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1.2 Plants as a source of food 
Food is any substance composed primarily of carbohydrates, fats, water, and /or proteins 
that can be drunk or eaten by human beings or animals for nutrition or pleasure (figure 1.1). 
Food sources include plants, animals or other categories such as fungus or fermented 
products like alcohols (Davidson, 2006). 
Many plant or plant parts are eaten as food. There are around 2000 plants species which can 
be cultivated for food, and many have several distinct cultivars (Davidson, 2006; Mander, 
1999). Fruits are ripened extensions of plants including seeds within. Many plants have 
evolved fruits that are attractive as a food source to animals as well. Fruits, therefore, make 
up a significant part of the diets of most cultures. Some botanical fruits such as tomatoes, 
pumpkin etc are eaten by humans as vegetables. 
 
 
Fats, Oils and Sweets
Vegetables
Breads, Grants and Other Starches
                    Meat,
Meat Substitutes
           and Other
              Proteins
Fruits
Milk
 
Fig. 1. Food pyramid (http://dietmotion.com/images/food-pyramid.jpg) 
1.3 Drug discovery 
Although natural products, particularly secondary metabolites, have formed the basis of 
medicines, the presence of these compounds in the biochemistry of the plant is very often 
difficult to justify. It has been suggested that these compounds may have been synthesized 
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by the plant as part of the defence system of the plant, e.g. plants are known to produce 
phytoalexins as a response to attack by bacteria and fungi (Louw et al, 2002). The presence 
of highly toxic natural products has also been highlighted in some animals namely the 
Amazonian frogs so as to deter predation by other animals. Whatever the reasons for the 
presence of these compounds in nature could be, it is needless to state that they provide 
invaluable resources that have been used to find new drug molecules. Table 1.1 gives an 
indication of the development of new drugs from natural products. Spectroscopic methods 
coupled with good extraction techniques like chromatography, have contributed to the 
phenomenal success of natural product chemistry over the past 50 years. A sound isolation 
strategy has helped in the isolation and characterisation of many bioactive molecules. 
Nowadays, bioassay-guided fractionation of medicinal plants is a feature of routine in the 
attempt to isolate components from natural sources. These techniques are not only being 
restricted to plant sources but they are also being applied to microbial and even fungal 
sources of metabolites. In practice as soon as the material is collected, in the case of plants, it 
needs to be identified by a taxonomist so as to ascertain the correct identity of the material. 
Voucher specimens for herbarium specimens are kept. Various parts of the plant are 
collected separately (leaves, flowers, stem, wood, bark, root, root bark etc.) and are dried 
quickly in drying cabinets preparing them for isolation of active compounds (Gurib-Fakim, 
2006). 
 
Drugs/ chemical Action Plant source 
Acetyldigoxin Cardiotonic Digitalis lanata  
(Grecian foxglove, woolly foxglove) 
Adoniside Cardiotonic Adonis vernalis  
(pheasant's eye, red chamomile) 
Caffeine CNS stimulant Camellia sinensis  
(tea, also coffee, cocoa and other plants) 
Camptothecin Anticancerous Camptotheca acuminate 
 
Colchicine Antitumor, 
antigout 
Colchicum autumnale  
(autumn crocus) 
Galanthamine Cholinesterase 
inhibitor 
Lycoris squamigera  
(magic lily, resurrection lily, naked lady) 
Glycyrrhizin Sweetener, 
treatment for 
Addison's disease 
Glycyrrhiza glabra  
(licorice) 
Irinotecan Anticancer, 
antitumor agent 
Camptotheca acuminate 
Lapachol Anticancer, 
antitumor 
Tabebuia species  
(trumpet tree) 
Monocrotaline Topical antitumor 
agent 
Crotalaria sessiliflora 
Table 1.1 Plant based drugs and medicines (Taylor, 2000) 
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1.4 Plants as a source of cosmetics 
Cosmetic product refers to any substance or preparation intended for application to any 
external surface of the human body (i.e. the epidermis, hair system nails, lips and external 
genitals organs) or teeth or buccal mucosa wholly or mainly for the purpose of cleaning, 
perfuming or protecting them or keeping them in good conditions or changing their 
appearance or combating body odour or perspiration except where such cleaning, 
perfuming, protecting, keeping and changing is wholly for the purpose of treating or 
preventing diseases (Aburjai and Natsheh, 2003; Dweck, 1996). Novel bioactive ingredients 
for cosmetics are derived from sea, earth and plant kingdom. Popular ingredients include 
Chinese herbs, Vitamins, minerals, antioxidants, enzymes, hormones and naturals.  
Plants have been used for cosmetic purposes since time immemorial. They have once been 
the main source and foundation of all cosmetics before various methods were discovered of 
synthesizing substances with similar properties (Aburjai and Natsheh, 2003). The first 
cosmetic derived from plant is dated about 3100-2907 BC which was used in Egypt (Dold 
and Cocks, 2002; Cocks et al, 2003).  
There are many plants which are being used for cosmetics. Ginseng is a traditional drug 
used for more than 2000 years. It activates the skin metabolism (Tanaka and Okada, 1991), 
reduces keratinisation (Kim et al, 1989), provides moisture and softens, alleviate wrinkling 
and enhance skin whiteness (Dweck, 1997). Other plants that have been used in cosmetics 
preparations are Artemisia vulguris and Artemisia absinthum which are used for skin diseases. 
The entire plant is made into decoction and is used as a wash for many kinds of wounds and 
skin ulcers (Dweck, 1997). Salvia officinalis (L) also called common sage, true sage or garden 
sage is used as a lotion to improve the condition of hair and skin. The major S. officinalis 
constituents responsible for the effect of hair are tannins, saponins as well as borneol and 
camphor (Aburjah and Natsheh, 2003; Boiceanu et al, 1986). Majority of South African plants 
such as Calodendrum capensis, are being used traditionally as cosmetics but they have not 
been scientifically validated. 
2. Hyper-pigmentation 
Hyper-pigmentation of skin is a common problem that is prevalent in middle aged and 
elderly people. Hyper-pigmentation can be caused by excessive exposure to UV light, drug 
reaction and can also occur during ageing. Dermatological disorders associated with hyper-
pigmentation include age spots, melasma and site of actinic damage to mention the few 
(Pandya and Guevera, 2000).  
Melanin is the pigment responsible for the colour of skin in humans. It also occurs in 
bacteria, fungi and plants. Tyrosinase is known to be the key enzyme in melanin 
biosynthesis (Nerya et al, 2003). Over-activity of this enzyme leads to overproduction of 
melanin leading to hyper-pigmentation of the skin and under-activity leads to disorders 
such as vitiligo (depigmentation spots that occurs on the skin) and whitening of hair. 
Overproduction of melanin can be prevented by avoiding excessive UV light exposure and 
can be treated with skin-lightening agents such as bleaching hydroquinone, kojic acid and 
retinoids (Halder et al, 2004). Inhibition of tyrosinase can also lead to reduced melanin 
production. Some commercially available chemical and fungal derived skin-lightening 
agents have been proven to have chronic, cytotoxic, mutagenic effects in humans (Nerya et 
al, 2003; Wang et al, 2006; Wu et al, 2003). Therefore, there is a need for alternative herbal 
derived and pharmaceutical agents for the treatment of hyper-pigmentation of human skin. 
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2.1 Structure and function of the skin 
The skin is one of the heaviest body organs. It covers between 1.5 and 2 m, comprising about 
one sixth of the body’s total weight. The skin performs several important physiological 
functions; this includes regulation of body temperature and metabolism, excretion (via 
sweat glands), synthesis of vitamin D in the epidermal layer when exposed to UV rays, uses 
specialised cells to protect us from UV rays of the sun etc (Murphy, 1995). The skin consists 
of three layers (figure 2.1) namely: 
i. Epidermis- It is the outer layer of the skin which also consists of several layers- the 
basal cell layer, the spinous cell layer, the granular cell layer and the stratum corneum. 
Cells in the epidermis include the keratinocytes which are the most abundant cells in 
this layer, melanocytes which constitutes about 5% of the living cells in this layer 
(Murphy, 1995). 
ii. Dermis- This layer is just below the epidermis. It consists of fats, collagen and also 
elastin fibres that provide strength and flexibility to the skin. In older persons the 
elastin fibres fragments and much of the skin’s elastic quality is lost. This, along with 
the loss of subcutaneous fat, results in wrinkles (Murphy, 1995). 
iii. Subcutaneous layer or hypodermis- This is the inner most layer of the skin. It serves as 
storage for fats. The fats stored in this layer represent an energy source for the body and 
helps to insulate the body against changes in the outside temperature (Murphy, 1995). 
 
 
Fig. 2. Structure of the normal skin 
(http://skincare.dermis.net/content/e01aufbau/e660/e661/e700/013_haut_aufbau_eng.gif) 
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2.2 Melanin biosynthesis and its importance 
Melanin is a class of compounds found in the plant, animal and protista kingdoms, where it 
serves predominantly as a pigment (Kim and Uyama, 2005). In humans, melanin is the 
primary determinants of the color of the skin, hair and eyes. It is synthesized within 
melanosomes, membrane-bound granules, from melanocytes and is then transferred to 
keratinocytes through a physiological process called melanogenesis (figure 2.2) (Ancans et al, 
2003; Kim and Uyama, 2005). Tyrosinase is known to be the key enzyme in melanin 
biosynthesis (figure 2.2). It catalyses two distinct reactions: hydroxylation of the amino acid 
tyrosine to 3,4 dihydroxyphenylalanine (DOPA) by monophenolase action and oxidation of 
DOPA in to o-dopaquinone by diphenolase action. This o-quinone is transformed into 
melanins in a series of non-enzymatic reactions (Baurin et al, 2002; Wang et al, 2006). There 
are two types of melanin pigments that can be produced by the melanocytes cells namely: 
‘eumelanin’ (black or brown) and ‘pheomelanin’ (red or yellow) (figure 2.3) (Commo et al, 
2004; Summers, 2006). The color of hair, skin etc in human is determined by the type, 
distribution and degree of melanin pigment synthesized. Each individual of different racial  
 
 
Fig. 3. Melanin biosynthesis pathway (Moss, 2005) 
(http://www.chem.qmul.ac.uk/iubmb/enzyme/reacqwa tion/AminoAcid/melanin.html) 
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group have more or less the same number of melanocytes cells, thus the type of melanin  
produced depends on the functioning of the melanocytes e.g. people with darker skin are 
just genetically programmed to constantly produce higher levels of melanin even without 
exposure to UV light and the melanosomes remains singular (figure 2.4) (Commo et al, 2004; 
Baurin et al, 2002; Kim and Uyama, 2005; Summers, 2006; Sturm et al, 1998). In individuals 
with fair or lighter skin colour, melanosomes cluster in membrane bound organelles (figure 
2.4) (Sturm et al, 1998). The role of melanin is to protect the skin against UV light damage by 
absorbing UV sunlight and by removing reactive oxygen species (Kim and Uyama, 2005; 
Summers, 2006). 
 
 
Fig. 4. Production of different pigments by melanosomes (Simon et al, 2008) 
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Singular
melanosomes 
 
Clustered
melanosomes 
 
Fig. 5. Structure of melanosome distribution for different racial groups (Sturm et al, 1998) 
2.3 Factors affecting skin pigmentation 
The process of melanogenesis is affected by a variety of environmental, hormonal and 
genetic factors. Environmental factors include excessive exposure to UV light, which 
induces immediate pigment-darkening due to swelling and re-alignment of melanosomes 
(Rendon, 2003, Schulleuter et al, 1998; Simon et al, 2008). Example for hormonal factors is 
evident in pregnant women whereby during this period, dark brown patches occur on the 
forehead, face, cheeks and it can occur due to reactions caused by usage of drugs. Genetic 
factors are evident in cases like albinism whereby individuals loses the TPR1 gene which 
disrupts the correct formation of the melanosomal complex and thereby inhibits melanin 
synthesis, resulting in hypopigmented phenotype (Sturm et al, 1998) 
2.4 Hyper-pigmentation disorders 
Hyper-pigmentation is a common and distressing problem. Females report more often, 
although not rare in males. These disorders have a tremendous psychological impact 
especially in females. There are different kinds of hyper-pigmentation disorders that are 
encountered during life. Some of them are as follows: 
2.4.1 Age spots 
This is also known as brown spots, lentigines or liver spots. They usually appear on the 
hands, but can also appear on the face, arm and feet as brown patches. They are harmless 
and are caused by excessive exposure of the skin to the sun. It may also be caused by 
nutritional deficiency, impaired liver function dietary and ageing (Moss, 2005, Murphy, 
1995).  
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2.4.2 Melasma 
Melasma appears as blotchy, brownish pigmentation on the face of adults. Both sides of the 
face are usually affected. The most common sites of involvement are the cheeks, bridge of 
nose, forehead, and upper lip. The precise cause of melasma is unknown. People with a 
family history of melasma are more likely to develop melasma themselves. A change in 
hormonal status may trigger melasma. It is commonly associated with pregnancy and is also 
called chloasma, or the "mask of pregnancy." Birth control pills may also cause melasma, 
however, hormone replacement therapy used after menopause has not been shown to cause 
the condition. Sun exposure also contributes to melasma. While there is no cure for 
melasma, many treatments have been developed. Melasma may disappear after pregnancy; 
it may remain for many years, or a lifetime. Sunscreens are essential in the prevention of 
melasma (American Academy of Dermatologists press 2008; Montemarano, 2008; Daniel et 
al, 2003). 
2.4.3 Freckles 
Freckles are clusters of concentrated melanin which are most often visible on people with a 
fair complexion. A freckle is also called an “ephelis”. They can be found on anyone no 
matter the background; however, having freckles is genetic and is related to the presence of 
the dominant melanocortin-1 receptor (MC1R) gene variant. The formation of freckles is 
triggered by exposure to sunlight. The exposure to UV-B radiation activates melanocytes to 
increase the melanin production, which causes freckles to become darker. Freckles are 
predominantly found on the face, although they may appear on any skin exposed to the sun. 
Freckles are rare on infants and more common on children before puberty; they are less 
common on adults (Hanson et al, 2006; Daniel et al, 2003). 
2.4.4 Melanoma 
Excessive exposure to the sun is the most common cause of skin darkening. The darkening 
is due to the skin's increased production of melanin, which is a protective mechanism 
against the sun's harmful ultraviolet rays. In the last few decades, a suntan has been equated 
with a healthy, outdoor look, and large numbers of ordinarily fair-skinned people have 
deliberately exposed their skin to the sun to acquire suntans. This practice has led to an 
alarming rise in skin cancer, including malignant melanoma, which is often fatal. 
Fortunately, fashion is beginning to change, and deeply tanned skin is no longer considered 
chic. 
Melanoma, also referred to as “malignant melanoma,” is the most serious form of skin 
cancer because - with the exception of some rare forms of skin cancer - it is the skin cancer 
most likely to spread to lymph nodes and internal organs. Today, melanoma accounts for 
77% of all deaths from skin cancer. 
Dermatologists believe that the number of deaths from melanoma could be significantly 
reduced if more people were able to recognize melanoma in its earliest stages. It is 
important to know that there are different types of melanoma. This article describes the four 
most common types of melanoma, which accounts for about 100% of diagnosed cases. 
Below you will find an explanation of what each of these four types of melanoma looks like 
and important points to remember. Here are a few of these key points: 
• With early detection and treatment, the cure rate for melanoma is about 95%.  
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• Not all melanoma develops from a changing mole. Melanoma also can appear where 
there was not a previous lesion and look like a non-pigmented scar or cyst. 
• Melanoma can appear as a nail streak or non-healing bruise. 
Four types of melanoma  
1. Superficial spreading melanoma (about 70% of diagnosed cases) 
2. Nodular melanoma (about 15% of diagnosed cases) 
3. Lentigo maligna melanoma (about 10% of diagnosed cases) 
4. Acral lentiginous melanoma (about 5% of diagnosed cases) 
2.4.4.1 Superficial spreading melanoma 
Superficial spreading melanoma (SSM) is the most common type of melanoma in the United 
States, accounting for about 70% of all diagnosed melanoma cases. This type of melanoma 
can strike at any age and occurs slightly more often in females than males. SSM is the 
leading cause of death from cancer in young adults. 
When SSM occurs in females, it most commonly appears on the legs. In males, it is more 
likely to develop between the neck and pelvis. However, this does not mean that females do 
not get SSM on their trunks or that males do not see SSM on their legs. This melanoma can 
occur anywhere on the skin’s surface. 
A typical SSM lesion has: 
• Irregular borders 
• Various shades of black, brown, gray, blue, pink, red, or white. Within the lesion there 
can be a remarkable variation in color involving white, pink, brown, and black. 
In the early stages, SSM usually appears as a flat spot that looks like a freckle that is 
spreading sideways on the skin. Over time, the pigmentation in the lesion may darken, and 
the lesion may grow, develop increasingly irregular borders, and have areas of 
inflammation within the lesion. The area around the lesion may begin to itch. Occasionally, 
a SSM may become “less” pigmented as a person’s immune responses try to destroy it. If a 
lesion becomes less pigmented, this does not mean that the lesion no longer requires 
treatment. It definitely needs to be examined by a dermatologist.  
Superficial spreading melanoma can progress rapidly. If you see a lesion that you suspect 
could be melanoma, have it examined by a dermatologist. 
2.4.4.2 Nodular melanoma 
Nodular melanoma (NM) is the most aggressive type of melanoma and accounts for about 
15% of all melanomas diagnosed in the United States. It can appear anywhere on the body 
and occurs more often in males than females. It can develop at any age; however, it is most 
often seen in people aged 60 and older. 
NM differs from other types of melanoma in three ways:  
• Tends to grow more rapidly in thickness (penetrate the skin) than in diameter  
• May not have a readily visible phase of development 
• Instead of arising from a pre-existing mole, it may appear in a spot where a lesion did 
not previously exist 
Since NM tends to grow deeper more quickly than it does wide and can occur in a spot that 
did not have a previous lesion, the prognosis is often worse because it takes longer for a 
person to be aware of the changes. 
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NM is most often darkly pigmented; however, some NM lesions can be light brown or even 
colorless (non-pigmented). A light-colored or non-pigmented NM lesion may escape 
detection because the appearance is not alarming. An ulcerated and bleeding lesion is 
common. 
The following photos show diagnosed cases of NM, which often appears as a dome-shaped, 
darkly pigmented lesion. 
If a lesion appears where none existed before, have it examined as soon as possible by a 
dermatologist. 
2.4.4.3 Lentigo maligna melanoma 
Lentigo maligna melanoma (LMM) typically occurs on sun-damaged skin in the middle-
aged and elderly, especially on the face. This melanoma may be mistaken in its early, and 
most treatable, stages for a benign "age spot" or "sun spot.” LMM accounts for about 10% of 
the melanomas diagnosed in the United States. Since LMM is so easily mistaken, it can go 
undetected for years. This can be quite dangerous. 
LMM begins as a spreading, flat, patch with irregular borders and variable colors of brown. 
This lesion is called “lentigo maligna.” This spreading brownish patch may grow slowly for 
years and is often mistaken for lentigo simplex — a benign (non cancerous) brownish patch 
that can develop in the elderly after years of sun exposure. 
As the lesion grows and evolves, both the pigmentation and borders tend to become  
more irregular. This often occurs slowly over a period of 10 to 15 years. It also can happen 
rapidly — in a matter of weeks or months. As the lesion grows deeper into the skin 
(thickness increases), it may become various shades of black and brown. Dark nodules may 
appear within the irregular borders. These nodules are the invasive tumor, and if large 
enough to be felt by touch, will feel lumpy. 
If you have a large pigmented patch of skin, especially one with an irregular border, see a 
dermatologist as soon as possible. 
2.4.4.4 Acral lentiginous melanoma 
In the United States, acral lentiginous melanoma (ALM) accounts for about 5% of all 
diagnosed melanomas. It also is the most common form of melanoma in Asians and people 
with dark skin, accounting for 50% of melanomas that occur in people with these skin 
types.  
ALM is sometimes referred to as a “hidden melanoma” because these lesions occur on parts 
of the body not easily examined or not thought necessary to examine. ALM develops on the 
palms, soles, mucous membranes (such as those that line the mouth, nose, and female 
genitals), and underneath or near fingernails and toenails. 
ALM is often overlooked until it is well advanced because in the early stages, it often looks 
like a bruise or nail streak. Here is what it usually looks like on each area of the body: 
• Palm or sole – Melanoma usually begins as an irregularly shaped tan, brown, or black 
spot. It is often mistakenly attributed to some recent injury — that is, the patient recalls 
a relatively recent bruise or blow in the general area of the pigmented spot.  
• Mucous membranes – When melanoma develops on a mucus membrane, it is most 
likely to develop inside the nose or mouth. Early symptoms include nosebleeds and 
nasal stuffiness and a pigmented mass inside the mouth. Melanomas also can develop 
on the mucous membranes of the anus, urinary tract, and female genitalia. 
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• Under a nail - The first sign may be a "nail streak" — a narrow, dark stripe under the 
nail. ALM usually develops on the thumb or big toe; however, it can occur under any 
fingernail or toenail. Many individuals, especially dark-skinned people, have fixed nail 
streaks that are completely benign. A new nail streak not associated with recent trauma, 
an enlarging nail streak, a wide or very darkly pigmented streak, or a nail that is 
separating or lifting up from the nail bed should be examined by a dermatologist. A 
possible indication of advanced ALM is a nail streak with associated pigmentation in 
the nail fold skin or destruction of the nail plate.  
ALM of the fingers or toes also can develop without an obvious nail streak — particularly 
the non-pigmented variety. ALM may, for example, look very much like a chronic infection 
of the nail bed. As an ALM tumor increases in size, it usually becomes more irregular in 
shape and color. However, some ALM lesions can be lightly colored or colorless. The 
surface of the ALM lesion may remain flat, even as the tumor invades deeply into the skin. 
Thickening ALM on the sole of the foot can make walking painful and be mistaken for a 
plantar wart. 
The second photo shown above depicts an advanced tumor. This patient believed he had a 
long-standing bruise on his toe and refused to be examined by a physician. By the time 
ALM was finally diagnosed and surgically removed, it had invaded deeply into tissue and 
spread to other organs. The patient died of metastatic melanoma. 
Be sure to see a dermatologist as soon as possible if you notice a: 
• Bruise that does not fade or comes and goes 
• Nail lifts up or separates from the nail bed 
• New nail streak not associated with recent trauma  
• Enlarging nail streak 
• Wide or very darkly pigmented nail streak  
• Pigmented mass in the mouth  
• Nosebleeds and nasal stuffiness 
2.4.4.5 Non-pigmented subtypes 
While uncommon, melanoma occasionally does not have brown or black pigmentation. An 
uncommon subtype called amelanotic melanoma usually appears as a pink or red nodule 
(lump). Another uncommon subtype, desmoplastic neutrotrophic melanoma (DNM), 
usually looks like a non-pigmented scar. When a scar or keloid appears on the skin and the 
skin has not been injured, DNM is suspected. The lesion also can appear as a cyst that may 
or may not be pigmented. DNM tends to appear on sun-damaged skin in elderly patients, 
occurring mostly on the head and neck. 
3. Treatment of hyper-pigmentation 
Like other disorders hyper-pigmentation of the skin can be treated. Depending on the type 
and depth of pigmentation different treatment procedures are followed. The use of sun 
screens is important and this helps to reduce the development of pigmentation disorders. 
Skin lighteners are also used for the treatment of hyper-pigmentation this includes 
chemicals such as bleaching hydroquinone, retinoid etc which are available commercially 
(Cayce et al, 2004, Tiedtke et al, 2004). 
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3.1 Commercially available skin-lighteners 
There are different types of skin-lightening agents that are available commercially to combat 
dark marks or skin hyper-pigmentation. Some of these chemically derived compounds have 
shown to have poor penetration of the skin and shows some cytotoxic and mutagenic effect 
on people. Among treatments the use of chemicals such as ‘Kojic acid’, ‘Hydroquinone’, 
‘Arbutin’, ‘Aloesin’ etc are the most common ones. Descriptions of some of these chemicals 
are as follows: 
3.1.1 Hydroquinone (HQ) 
It is a hydroxyphenolic chemical that inhibits the conversion of L-DOPA to melanin by 
inhibiting the tyrosinase enzyme. Some of the possible mechanisms of action are the 
destruction of melanocytes, degradation of melanosomes and inhibition of the synthesis of 
DNA and RNA (Mashhood, 2006). Concentrations of HQ in commercially available 
formulations vary from 2% to 4%. Clinically and historically evaluation demonstrated clear 
improvements in most patients during the study done by Pandya and Guevara 2003. 
However, during this study 72% of the patients showed to develop irritant dermatitis over 
time, despite the low frequency of application. 
3.1.2 Kojic acid (5-hydroxy-2-[hydroxyl methyl]-4-pyrone) 
It is a naturally occurring hydrophilic, ‘fungal derivative’, evolved from certain species of 
Acetobater, Aspergillus and Penicillin. It acts by inhibiting the production of free tyrosinase 
with efficacy similar to hydroquinone. In Japan, kojic acid has been increasingly used in skin 
products. This is because until recently, topically applied kojic acid at 1% concentration had 
not exhibited any sensitizing activity. However, more recent long term Japanese studies 
have shown that kojic acid has a potential of causing ‘contact dermatitis’ and ‘erythema’ 
(Nakagawa et al, 1995; Mashhood, 2006). 
3.1.3 Arbutin (b-D-glucopyranoside derivative of hydroquinone) 
It is a naturally occurring plant derived compound that has been used for post-
inflammatory hyper-pigmentation. The action of arbutin depends on its concentration 
(Maeda and Fukuda, 1996). Higher concentrations are more efficacious than lower 
concentrations. A dose-dependent reduction in tyrosinase activity, as well as melanin 
content in melanocytes, is demonstrated. It was reported that it may cause paradoxical 
hyper-pigmentation (Mashhood, 2006).  
3.1.4 Aloesin 
It is a natural derivative of Aloe vera that inhibits tyrosinase at noncytotoxic concentrations. 
Aloesin acts as an inhibitor of DOPA oxidation. It is an experimental product and thus it is 
not available clinically (Rendon & Gaviria, 2005).  
4. Cosmeceutical formulations from plants 
Due to instability, poor penetration of the skin, irritation and mutagenic effects of chemical 
and fungal derived compounds in cosmetical applications, humans opt for herbal products 
for the treatment of different types of skin problems. There are many South African plants 
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which are being used in herbal cosmetics. Rooibos (Aspalathus linearis) is famous for being 
naturally caffeine free (Morton, 1983) and its low tannin content minimizes the risk of 
reduced iron absorption, a phenomena frequently found in tea drinkers due to iron-tannin 
complexation. Rooibos is rich in flavonoids, polyphenols, phenolic acids, oligosaccharides 
and polysaccharides (Dos et al, 2005). The major flavonoids found in Rooibos tea are 
aspalathin, iso-orientin, orientin and rutin (Shimamura et al, 2006). 
The skin is the largest organ of the body and is exposed to environmental oxidative stress. 
The incorporation of Rooibos extracts in topical cosmetic formulations has become very 
popular in recent years because it can target the site of action to reduce ultraviolet radiation 
damage and photo-aging (Mavon et al, 2005; Van Niekerk and Viljoen, 2008). Rooibos 
proved to exhibit anti-inflammatory and antimicrobial properties in cosmetic applications. 
According to earlier reports, hair growth was found to improve with the use of hair care 
products containing Rooibos. There are many herbal products derived from rooibos (fig 
2.5). 
 
  
 
 
Fig. 6. Rooibos (Aspalathus linearis) (http://www.inheritanceskincare.com/) 
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Artemisia afra is also popular for skin ailments. An infusion or decoction is used as a lotion 
by natives in South Africa to bathe hemorrhoids, herpes and venereal sores, while a hot 
bath in the decoction is used to bring out the rash in measles, mumps and chickenpox. The 
plant is also held in the mouth to ease the pain of boils and to hasten their bursting. It also 
has similar uses to Artemisia herba-alba and used externally on boils, carbuncles, and large 
acne pimples. A poultice of the leaf is applied locally to relieve neuralgia, to the swellings 
in mumps, and to any glandular or skin inflammation. A lotion is also made from the plant 
for washing the body and rejuvenating the skin (Dweck, 1996). Due to the above 
mentioned side effects and poor skin penetration ability of the existing agents which are 
used for the treatment of hyper-pigmentation, it is imperative to find alternative agents 
from plants. 
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